Related Experiment Video
Updated: Jun 24, 2026
09:00
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
[The German Clinical Trials Register: reasons, general and technical aspects, international integration]
G Dreier1, H Hasselblatt, G Antes
1Zentrum Klinische Studien, Universitätsklinikum Freiburg, Elsässer Strasse 2, 79110, Freiburg. gabriele.dreier@uniklinik-freiburg.de
Summary
The German Clinical Trials Register (GermanCTR) offers a central, open-access portal for clinical trial information in Germany. It facilitates searching and registering planned, ongoing, and completed trials, enhancing research transparency.
Area of Science:
- Medical Informatics
- Clinical Research Management
- Public Health Data
Context:
- Lack of a centralized, accessible platform for clinical trial information in Germany.
- Need for improved transparency and searchability of clinical research activities.
- Requirement for a national registry aligned with international standards (WHO, ICMJE).
Purpose:
- To establish a central online portal for clinical research information in Germany.
- To facilitate the search and registration of planned, ongoing, and completed clinical trials.
- To serve as an open-access resource for researchers, patients, and the public.
Summary:
- The German Clinical Trials Register (GermanCTR) was implemented as a WHO Primary Registry.
- It provides an open-access online platform for clinical trials conducted in Germany.
- GermanCTR allows users to search, register, and share information on clinical trials, adhering to ICMJE requirements.
Impact:
- Enhances the discoverability of clinical trials in Germany.
- Promotes transparency and collaboration in clinical research.
- Supports evidence-based medicine by providing access to trial data.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...